Perspective on susceptibility testing of anaerobic bacteria

Clinical Infectious Diseases

Volumn 25, Issue 2 SUPPL., 1997, Pages

  Finegold, Sydney M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL FLORA; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CLOSTRIDIUM; CONFERENCE PAPER; COST CONTROL; NONHUMAN; PRIORITY JOURNAL;

BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0030867584     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516233     Document Type: Article

References (2)

1. Finegold SM, Wexler HM. Present Status of therapy for anaerobic infections. Clin Infect Dis 1996;23(suppl 1):S9-14.
2. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. 3rd ed. NCCLS document M11-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.